News

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...
France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its anti-inflammatory drug Dupixent, as well as newer treatments and vaccines.
Explore QuantumScape's Q1 2025 earnings call insights, featuring progress on solid-state battery tech, Cobra process milestones, and partnerships ...
Neurocrine Biosciences' valbenazine shows promise as an adjunctive therapy for Schizophrenia, with phase 3 data expected in ...
Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...
Trump also threatened duties on Friday after his first set of "reciprocal" tariffs exempted pharmaceutical products. Trump has not said when and by how much he plans to raise levies on ...
Drug firms Glenmark and Biocon are recalling products in the US for manufacturing issues, according to the US health regulator. New Jersey-based Glenmark Pharmaceuticals Inc is recalling 8,160 bottles ...
The company has entered into a dossier licence, product supply, and technology knowhow licence agreement with Globalpharma Co. (LLC), a leading UAE-based pharmaceutical manufacturer, for ZIM Labs' ...
EU medical and pharmaceutical product exports to the US totalled about €90bn ($97.05bn) in 2023, according to the latest Eurostat data. European pharma giants have recently been expanding ...
Donald Trump has hinted at imposing tariffs on pharma products soon (AFP) India heaved a sigh of relief after US President Donald Trump exempted pharmaceuticals from his reciprocal tariff order last ...
In such cases, the manufacturer is required to take corrective action, which may include removing the product from the market or addressing the violation. Shares of Glenmark Pharmaceuticals Ltd. are ...